(17) reported that ARID1A variation was detected in 19/57 (26.3%) ICC patients and found that low ARID1A expression was dramatically correlated with worse OS (HR = 3.97, 95% CI: 1.299–12.118, P = 0.016). This evidence concerns the gene ARID1A and intrahepatic cholangiocarcinoma.